Article Details

Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of ...

Retrieved on: 2025-01-22 08:59:35

Tags for this article:

Click the tags to see associated articles and topics

Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of .... View article details on hiswai:

Excerpt

Sarclisa (isatuximab) is a CD38 monoclonal antibody that binds to a specific epitope on the CD38 receptor on MM cells, inducing distinct antitumor ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up